4.7 Editorial Material

Exploring the therapeutic space around NAD+

Journal

JOURNAL OF CELL BIOLOGY
Volume 199, Issue 2, Pages 205-209

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.201207019

Keywords

-

Categories

Funding

  1. AMC
  2. Ecole Polytechnique Federale de Lausanne
  3. EU [ERC-2008-AdG-23118]
  4. Velux Stiftung
  5. Swiss National Science Foundation [31003A-124713, CRSII3-136201]
  6. Swiss National Science Foundation (SNF) [31003A_124713, CRSII3_136201] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

NAD(+) is a central metabolite in the cell. Changes in NAD(+) abundance and the activity of NAD(+)-dependent enzymes, such as the sirtuins, are at the core of metabolic/mitochondrial diseases, such as obesity and diabetes, and of cancer and neurodegeneration. Here, we discuss how maintaining or raising NAD(+) levels can improve metabolism and prevent age-related functional decline and associated disease, and how basic scientific discoveries in the NAD(+) signaling pathway are being translated to the clinic.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available